Abstract
To explore effective and convenient rescue therapy options for coronary artery aneurysms (CAA) with thrombosis in Kawasaki disease (KD). A total of 210 patients with KD between the years 2003 and 2013 were retrospectively reviewed in our institute. 144 of these 210 KD developed CAA, and 10 patients with CAA had associated thrombosis. Thrombosis was confirmed by two-dimensional echocardiograms (2-DE). Laboratory values for CAA were analyzed with and without the thrombus group. The characteristics of CAA were monitored by ultrasound. All patients with thrombus received intravenous (IV) antithrombotic therapy, including urokinase, heparin, and oral warfarin. The effectiveness of antithrombotic treatment was evaluated by measuring the ability to dissolve the thrombus. All thrombi in these patients were preceded by a giant CAA and a history of KD. There are no differences in the blood analyses of both CAA with and without thrombus. Moreover, typical KD symptoms and acute myocardial infarction were not found in CAA with thrombosis. The progression of coronary thrombosis in these patients was arrested by antithrombotic and anti-platelet treatment including low-dose urokinase and heparin. Neither clinical features nor laboratory data could reliably predict CAA associated thrombosis. Therapy with IV anti-thrombus and anti-platelet treatment with low-dose warfarin can effectively dissolve thrombi in KD patients.
Similar content being viewed by others
References
Bonduel MM (2006) Oral anticoagulation therapy in children. Thromb Res 118:85–94
Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364:533–544
Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144–1148
Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148
Ebina T, Ishikawa Y, Uchida K, Suzuki S, Imoto K, Okuda J, Tsukahara K, Hibi K, Kosuge M, Sumita S, Mochida Y, Ishikawa T, Uchino K, Umemura S, Kimura K (2009) A case of giant coronary artery aneurysm and literature review. J Cardiol 53:293–300
Fukuhara S, Takase E, Fujimoto T, Takami Y, Yamamoto K, Nishida T, Morimoto A (2005) Coronary ectasia resulting in thrombotic coronary occlusion after warfarin interruption: a case report. J Cardiol 46:195–200
Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T et al (1984) High-dose intravenous gamma globulin for Kawasaki disease. Lancet 2:1055–1058
Gersony WM (1991) Diagnosis and management of Kawasaki disease. JAMA 265:2699–2703
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)—digest version. Circ J 74:1989–2020
Harada M, Akimoto K, Ogawa S, Kato H, Nakamura Y, Hamaoka K, Saji T, Shimizu T, Kato T (2013) National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease. Pediatr Int 55:690–695
Horigome H, Sekijima T, Miyamoto T (1997) Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart 78:517–518
Johnson PN, Kuhn RJ (2008) Combination thrombolytic and anti-platelet therapies in an infant with incomplete Kawasaki disease and coronary aneurysms. J Pediatr Pharmacol Ther 13:242–250
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385
Kobayashi H, Takazawa K, Matsumoto C, Ooi K, Nagata T, Katou K, Yoshida M, Aiga M, Aizawa A, Takahashi E, Namatame Y, Kinou M, Yamashina A (2006) The role of intravenous coronary thrombolysis for patients with acute myocardial infarction in different treatment strategies. Intern Med 45:709–714
Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388–392
Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S (2000) Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 42:470–475
Monagle P (2003) Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 29:547–555
Nakagawa M, Watanabe N, Okuno M, Okamoto N, Fujino H (2000) Effects of intracoronary tissue-type plasminogen activator treatment in Kawasaki disease and acute myocardial infarction. Cardiology 94:52–57
Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347
Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639
O’Brien M, Parness IA, Neufeld EJ, Baker AL, Sundel RP, Newburger JW (2000) Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics 105:E64
Okura N, Okuda T, Shiotani S, Kohno M, Hayakawa H, Suzuki A, Kawasaki T (2013) Sudden death as a late sequel of Kawasaki disease: postmortem CT demonstration of coronary artery aneurysm. Forensic Sci Int 225:85–88
Suzuki A, Kamiya T, Ono Y, Kohata T, Okuno M (1988) Myocardial ischemia in Kawasaki disease: follow-up study by cardiac catheterization and coronary angiography. Pediatr Cardiol 9:1–5
Tatara K, Kusakawa S (1987) Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 111:705–710
Terai M, Ogata M, Sugimoto K, Nagai Y, Toba T, Tamai K, Aotsuka H, Niwa K, Nakajima H (1985) Coronary arterial thrombi in Kawasaki disease. J Pediatr 106:76–78
Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85
Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 105:E78
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peng, H., Wu, Z., Liu, Y. et al. Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease. Pediatr Cardiol 36, 503–508 (2015). https://doi.org/10.1007/s00246-014-1040-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-014-1040-1